116
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Eyelash enhancement properties of topical dechloro ethylcloprostenolamide

&
Pages 110-113 | Received 10 Mar 2008, Accepted 13 Mar 2008, Published online: 12 Jul 2009

References

  • Sugimoto M., Sugimoto M., Uji Y. Quantitative analysis of eyelash lengthening following topical latanoprost therapy. Can J Ophthalmol 2002; 37: 342–5
  • Johnstone M. A., Albert D. M. Prostaglandin‐induced hair growth. Surv Ophthalmol 2002; 47((suppl 1))S185–202
  • Strober B. E., Potash S., Grossman M. E. Eyelash hypertrichosis in a patient treated with topical latanoprost. Cutis 2001; 67: 109–10
  • Johnstone M. A. Hypertrichosis and increased pigmentation of eyelashes and adjacent hair in the region of the ipsilateral eyelids of patients treated with unilateral topical latanoprost. Am J Ophthalmol 1997; 124: 544–7
  • Elgin U., Batman A., Berker N., Ilhan B. The comparison of eyelash lengthening effect of latanoprost therapy in adults and children. Eur J Ophthalmol 2006; 16: 247–50
  • McCarey B. E., Kapik B. M., Kane F. E. Unoprostone Monotherapy Study Group: Low incidence of iris pigmentation and eyelash changes in 2 randomized clinical trials with unoprostone isopropyl 0.015%. Ophthalmology 2004; 111: 1480–8
  • Chiba T., Kashiwagi K., Ishijima K., Furuichi M., Kogure S., Abe K., et al. A prospective study of iridial pigmentation and eyelash changes due to ophthalmic treatment with latanoprost. Jpn J Ophthalmol 2004; 48: 141–7
  • Doshi M., Edward D. P., Osmanovic S. Clinical course of bimatoprost‐induced periocular skin changes in Caucasians. Ophthalmology 2006; 113: 1961–7, Epub 2006 Aug 28
  • Kapur R., Osmanovic S., Toyran S., Edward D. P. Bimatoprost‐induced periocular skin hyperpigmentation: Histopathological study. Arch Ophthalmol 2005; 123: 1541–6
  • Abelson M. B., Mroz M., Rosner S. A., Dirks M. S., Hirabayashi D. Multicenter, open‐label evaluation of hyperemia associated with use of bimatoprost in adults with open‐angle glaucoma or ocular hypertension. Adv Ther 2003; 20: 1–13
  • Mehta J. S., Raman J., Gupta N., Thuong D. Cutaneous latanoprost in the treatment of alopecia areata. Eye 2003; 17: 444–76
  • Mansberger S. L., Cioffi G. A. Eyelash formation secondary to latanoprost treatment in a patient with alopecia. Arch Ophthalmol 2000; 118: 718–19
  • Wolfe R., Matz H., Zalish M., Pollack A., Orion E. Prostaglandin analogs for hair growth: Great expectations. Dermatol Online J 2003; 9: 7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.